• Exploring VISTA and LRIG1 Interactions: Cancer Immunotherapy

  • Aug 22 2024
  • Duración: 17 m
  • Podcast

Exploring VISTA and LRIG1 Interactions: Cancer Immunotherapy

  • Resumen

  • Lily Wang, PhD, from the Department of Translational Hematology Oncology Research at Cleveland Clinic, joins the Cancer Advances Podcast to dive into her research on VISTA and LRIG1 interactions. Dr. Wang, an expert in immune mechanisms within cancer, discusses her lab's innovative work on these immune checkpoint proteins and their potential to overcome current treatment limitations. Discover how targeting the VISTA-LRIG1 axis could offer new strategies for tackling resistant tumors and improving patient outcomes.

    Más Menos
activate_Holiday_promo_in_buybox_DT_T2

Lo que los oyentes dicen sobre Exploring VISTA and LRIG1 Interactions: Cancer Immunotherapy

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.